Browse > Article
http://dx.doi.org/10.4110/in.2014.14.3.149

Insulin Resistance and Serum Levels of Interleukin-17 and Interleukin-18 in Normal Pregnancy  

Jahromi, Abdolreza Sotoodeh (Research Center for Cardiovascular Atherosclerosis)
Shojaei, Mohammad (Research Center for Cardiovascular Atherosclerosis)
Ghobadifar, Mohamed Amin (Department of Student Research Committee, Jahrom University of Medical Science)
Publication Information
IMMUNE NETWORK / v.14, no.3, 2014 , pp. 149-155 More about this Journal
Abstract
We performed this study to evaluate the role of Interleukin-17 (IL-17) and Interleukin-18 (IL-18) in insulin resistance during normal pregnancy. This descriptive cross sectional study was carried out on 97 healthy pregnant women including 32, 25, and 40 individuals in the first, second, and third trimesters, respectively, and on 28 healthy non pregnant women between the autumn of 2012 and the spring of 2013. We analyzed the serum concentrations of IL-17 and IL-18 by using the enzyme linked immunosorbent assay (ELISA). Insulin resistance was measured by homeostasis model assessment of insulin resistance equation. No significant differences between the demographic data of the pregnant and non pregnant groups were observed. Insulin resistant in pregnant women was significantly higher than the controls (p=0.006). Serum IL-17 concentration was significantly different in non pregnant women and pregnant women in all gestational ages (p<0.05). Serum IL-18 level was significantly lower in subjects with first, second, and third trimesters of pregnancy in compared to non pregnant women (p<0.05). No significant correlations were found between serum IL-17 and IL-18 levels with insulin resistance (r=0.08, p=0.34 vs. r=0.01, p=0.91, respectively). Our data suggested that IL-17 and IL-18 do not appear to attribute greatly to pregnancy deduced insulin resistance during normal pregnancy.
Keywords
Insulin resistance; Interleukin-17; Interleukin-18; Pregnancy;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Nakanishi, K., T. Yoshimoto, H. Tsutsui, and H. Okamura. 2001. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 12: 53-72.   DOI   ScienceOn
2 Ekelund, C. K., I. Vogel, K. Skogstrand, P. Thorsen, D. M. Hougaard, J. Langhoff-Roos, and B. Jacobsson. 2008. Interleukin-18 and interleukin-12 in maternal serum and spontaneous preterm delivery. J. Reprod. Immunol. 77: 179-185.   DOI
3 Sakai, M., A. Shiozaki, Y. Sasaki, S. Yoneda, and S. Saito S. 2004. The ratio of interleukin (IL)-18 to IL-12 secreted by peripheral blood mononuclear cells is increased in normal pregnant subjects and decreased in pre-eclamptic patients. J. Reprod. Immunol. 61: 133-143.   DOI
4 Jagannathan-Bogdan, M., M. E. McDonnell, H. Shin, Q. Rehman, H. Hasturk, C. M. Apovian, and B. S. Nikolajczyk. 2011. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J. Immunol. 186: 1162-1172.   DOI
5 Esposito, K., A. Pontillo, M. Ciotola, C. Di Palo, E. Grella, G. Nicoletti, and D. Giugliano. 2002. Weight loss reduces interleukin-18 levels in obese women. J. Clin. Endocrinol. Metab. 87: 3864-3866.   DOI
6 Manley, S. E., S. D. Luzio, I. M. Stratton, T. M. Wallace, and P. M. Clark. 2008. Preanalytical, analytical, and computational factors affect homeostasis model assessment estimates. Diabetes Care 31: 1877-1883.   DOI
7 Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.   DOI   ScienceOn
8 Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.   DOI   ScienceOn
9 Xu, S. and X. Cao. 2010. Interleukin-17 and its expanding biological functions. Cell Mol. Immunol. 7: 164-174.   DOI
10 Louten, J., K. Boniface, and R. de Waal Malefyt. 2009. Development and function of TH17 cells in health and disease. J. Allergy Clin. Immunol. 123: 1004-1011.   DOI   ScienceOn
11 Peck, A., E. D. Mellins. 2009. Breaking old paradigms: Th17 cells in autoimmune arthritis. Clin. Immunol. 132: 295-304.   DOI   ScienceOn
12 Clapp, J. F. 2006. Effects of Diet and Exercise on Insulin Resistance during Pregnancy. Metab Syndr Relat Disord. 4: 84-90.   DOI
13 Sallusto, F. and A. Lanzavecchia. 2009. Human Th17 cells in infection and autoimmunity. Microbes Infect. 11: 620-624.   DOI
14 Marzi, M., A. Vigano, D. Trabattoni, M. L. Villa, A. Salvaggio, E. Clerici, and M. Clerici 1996. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol. 106: 127-133.   DOI   ScienceOn
15 Saito, S., A. Nakashima, T. Shima, and M. Ito. 2010. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 63: 601-610.   DOI
16 Gwozdziewiczova, S., R. Lichnovska, and J. Hrebicek. 2004. Tumor necrosis factor alfa (TNFalpha) and insulin resistance. Cesk Fysiol. 53: 167-175.
17 Senn, J. J., P. J. Klover, I. A. Nowak, and R. A. Mooney. 2002. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51(12): 3391-3399.   DOI   ScienceOn
18 Zinman, B., A. J. Hanley, S. B. Harris, J. Kwan, and I. G. Fantus. 1999. Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 84: 272-278.
19 Ahmed, M. and S. L. Gaffen. 2010. IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev. 21: 449-453.   DOI   ScienceOn
20 Roland, L., A. Gagne, M. C. Belanger, M. Boutet, P. Julien, and J. F. Bilodeau. 2010. Plasma interleukin-18 (IL-18) levels are correlated with antioxidant vitamin coenzyme Q(10) in preeclampsia. Acta Obstet. Gynecol. Scand. 89: 360-366.   DOI   ScienceOn
21 Jahromi, A. S., P. Zareian, and A. Madani. Insulin resistance and interleukin-$1{\beta}$ during normal pregnancy. Asian J. Biochem. 6: 366-372.
22 Shearman, A. M., L. A. Cupples, S. Demissie, I. Peter, C. H. Schmid, R. H. Karas, M. E. Mendelsohn, D. E. Housman, and D. Levy. 2003. Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA 290: 2263-2270.   DOI   ScienceOn
23 Matthews, D. R., J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.   DOI   ScienceOn
24 Jahromi, A. S., P. Zareian, and A. Madani. 2011. Association of insulin resistance with serum interleukin-6 and TNF-alpha levels during normal pregnancy. Biomark Insights 6: 1-6.
25 Hadden, D. R. and C. McLaughlin. 2009. Normal and abnormal maternal metabolism during pregnancy. Semin. Fetal Neonatal Med. 14: 66-71.   DOI   ScienceOn
26 Baranyi, E. and G. Winkler. 2011. Diabetes and pregnancy. Orv Hetil. 152: 1635-1640.   DOI
27 Kirwan, J. P., S. Hauguel-De Mouzon, J. Lepercq, J. C. Challier, L. Huston-Presley, J. E. Friedman, S. C. Kalhan, and P. M. Catalano. 2002. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51: 2207-2213.   DOI   ScienceOn
28 Okamura, H., S. Kashiwamura, H. Tsutsui, T. Yoshimoto, and K. Nakanishi. 1998. Regulation of interferon-gamma production by IL-12 and IL-18. Curr. Opin. Immunol. 10: 259-264.   DOI
29 Escobar-Morreale, H. F., J. I. Botella-Carretero, G. Villuendas, J. Sancho, and J. L. San Millan. 2004. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J. Clin. Endocrinol. Metab. 89: 806-811.   DOI   ScienceOn
30 Saito, S., A. Nakashima, M. Ito, and T. Shima. 2011. Clinical implication of recent advances in our understanding of IL-17 and reproductive immunology. Expert Rev. Clin. Immunol. 7: 649-657.   DOI
31 Gaffen, S. L. 2009. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9: 556-567.   DOI   ScienceOn